What is Lenvatinib 4 mg?
Lenvatinib 4 mg is a prescription medication primarily used in the treatment of thyroid cancer. It contains the active ingredient Lenvatinib, which belongs to a class of drugs known as tyrosine kinase inhibitors. Manufactured by Cipla Limited, this medication offers a targeted approach to managing certain types of thyroid malignancies by inhibiting tumor growth and progression.
Approved for use in various countries including Canada, Lenvatinib 4 mg is administered under strict medical supervision. This medicine plays a significant role in managing patients with differentiated thyroid cancer that has progressed or is unresectable, helping improve clinical outcomes and quality of life.
Uses of Lenvatinib 4 mg
- Treatment of differentiated thyroid cancer not responsive to radioactive iodine therapy
- Management of unresectable thyroid tumors
- Control of tumor growth in advanced thyroid cancer cases
- Part of combination therapy regimens for advanced thyroid malignancies
How Lenvatinib 4 mg Works
Lenvatinib 4 mg works by selectively inhibiting multiple receptor tyrosine kinases involved in tumor angiogenesis and cancer cell proliferation. These receptors include vascular endothelial growth factor receptors (VEGFR 1, 2, and 3), fibroblast growth factor receptors (FGFR 1-4), platelet-derived growth factor receptor alpha (PDGFRα), RET, and KIT. By blocking these pathways, Lenvatinib helps reduce the blood supply to tumors, limiting their growth and ability to spread.
This targeted mechanism distinguishes Lenvatinib from traditional chemotherapy, offering a more focused treatment option with the potential for fewer systemic side effects. It is especially useful in treating thyroid cancers that have become resistant to other therapies.
Benefits of Lenvatinib 4 mg
- Effectively slows the progression of advanced thyroid cancer
- Targets multiple cancer pathways simultaneously
- Oral administration for convenient dosing
- Can be combined with other cancer therapies safely
- Helps improve disease control and patient quality of life
Dosage and Administration
The dosage of Lenvatinib 4 mg is determined by the prescribing healthcare professional based on the patient’s medical condition and response to treatment. It is usually taken orally once daily, with or without food, at the same time each day to maintain consistent blood levels.
It is very important to follow the prescribed schedule strictly and not to alter the dose without consulting a doctor. Regular monitoring and follow-up appointments are essential to ensure proper management of any side effects or dose adjustments. A higher strength is also listed as lenvatinib 10 mg.
Who Should Use Lenvatinib 4 mg?
Lenvatinib 4 mg is intended for adults diagnosed with:
- Differentiated thyroid cancer that is refractory to radioactive iodine
- Advanced or metastatic thyroid tumors unsuitable for surgery
- Patients for whom conventional therapies have been ineffective
Use should only be initiated under specialist oncology care with appropriate diagnostic confirmation. After thyroid surgery, some patients also need thyroid hormone replacement such as liothyronine sodium, as directed by their care team.
Who Should Avoid Lenvatinib 4 mg?
- Individuals with known hypersensitivity to Lenvatinib or any components of the formulation
- Patients with uncontrolled high blood pressure
- Pregnant or breastfeeding women unless clearly necessary and under strict supervision
- Patients with recent history of bleeding disorders or risk of hemorrhage
- Those with severe liver or kidney impairment unless advised by a healthcare provider
Side Effects
- Hypertension (high blood pressure)
- Fatigue and tiredness
- Diarrhea
- Nausea
- Loss of appetite
- Weight loss
- Skin rash
- Mouth sores
- Headache
- Dizziness
- Proteinuria (protein in urine)
- Hand-foot syndrome (redness, swelling, pain on palms and soles)
- Increased liver enzymes
- Bleeding or bruising easily
- Shortness of breath
Safety Advice
- Monitor blood pressure regularly during treatment
- Report any signs of bleeding or unusual bruising to a doctor immediately
- Notify your physician if you experience severe diarrhea or dehydration
- Avoid pregnancy while using Lenvatinib and use effective contraception
- Do not stop taking the medication abruptly without consulting your healthcare provider
- Inform your healthcare provider about all other medications and supplements you are taking
- Maintain regular liver and kidney function tests during therapy
- Stay hydrated and maintain a balanced diet to support treatment tolerance
Drug Interactions
- Other blood pressure medications may require adjustment
- Drugs that affect liver enzymes (CYP3A4 inhibitors or inducers)
- Anticoagulants or blood-thinning agents
- Certain antifungals and antibiotics
- Medications that affect heart rhythm
- Other kinase inhibitors, such as cabozantinib, which are not normally combined without specialist advice
Storage Instructions
Store Lenvatinib 4 mg tablets in a cool, dry place away from direct sunlight. Keep the medication in its original packaging to protect it from moisture. Ensure it is stored out of reach of children and pets. Do not use the medication beyond the expiry date indicated on the packaging.
Where to buy Lenvatinib 4 mg in Canada?
Lenvatinib 4 mg can be purchased at licensed Canadian pharmacies with a valid prescription from a healthcare provider. It is crucial to obtain the medication from reputable sources to ensure authenticity and safety. Many online Canadian pharmacies offer secure purchasing options and home delivery services, providing convenience and privacy for patients.
Frequently Asked Questions (FAQ)
Is Lenvatinib 4 mg available in Canada?
Yes, Lenvatinib 4 mg is approved and available in Canada through licensed pharmacies with a prescription from an oncologist or qualified healthcare provider.
What is the price of Lenvatinib 4 mg in Canada?
Prices vary depending on the pharmacy and insurance coverage. It is recommended to check with multiple reputable pharmacies for current pricing and possible insurance support.
What happens if I miss a dose?
If a dose is missed, take it as soon as possible unless it is almost time for the next dose. Do not double the dose to catch up. Consult your doctor for guidance.
Where can I find Lenvatinib 4 mg for sale?
You can find Lenvatinib 4 mg for sale at licensed Canadian pharmacies both online and in-store, always requiring a valid prescription.
Can I take Lenvatinib 4 mg with other medications?
Some medications may interact with Lenvatinib. Inform your healthcare provider about all drugs you are taking to avoid adverse interactions.
Are there any special precautions before starting Lenvatinib 4 mg?
Your healthcare provider will perform necessary tests like blood pressure, liver and kidney function before starting treatment to ensure safety.
How long does it take to see results from Lenvatinib 4 mg?
The response time varies per patient. Regular monitoring through imaging and clinical assessments will guide treatment evaluation.
Conclusion
Lenvatinib 4 mg is a vital targeted therapy option for patients managing advanced thyroid cancer resistant to standard treatments. Its action on several receptors involved in tumor growth makes it effective in controlling disease progression. Cipla Limited ensures high-quality manufacturing standards, providing patients in Canada with access to this important medication. Always use Lenvatinib under medical supervision and follow prescribed guidelines to maximize its benefits while minimizing risks. Mayo Clinic describes lenvatinib oral use, side effects and dosage.
Leave A Review